UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -0.9% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 157 | +4 | 27.98M | $15.17B | +8 | −5 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | n/a |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | n/a | n/a |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | n/a |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | n/a | n/a |
| Q2 2024 | 14 | n/a | 8.17M | $2.60B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 5.33M | n/a | $1.53B | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 2 | The Vanguard Group ✦ (pasif) | 4.45M | n/a | $1.28B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasif) | 2.17M | -2.8% | $622.83M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 2.12M | +0.6% | $608.92M | 0.8% | ▲ Add | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.44M | -28.8% | $414.63M | 0.1% | ▼ Trim | 5 | SEC ↗ ×7 |
| 6 | AQR Capital Management ✦ | 1.27M | +40.1% | $362.88M | 0.3% | ▲ Add | 5 | SEC ↗ ×5 |
| 7 | Geode Capital Management ✦ (pasif) | 1.20M | -1.9% | $344.26M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (pasif) | 474.87K | +1.8% | $136.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 424.24K | n/a | $121.91M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 10 | Arrowstreet Capital ✦ | 339.09K | -14.8% | $97.44M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 11 | Marshall Wace ✦ | 276.48K | +29.8% | $79.45M | 0.1% | ▲ Add | 2 | SEC ↗ ×3 |
| 12 | Bridgewater Associates ✦ | 195.12K | +0.7% | $56.07M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 141.01K | +289.7% | $40.52M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 14 | T. Rowe Price ✦ | 114.50K | -39.6% | $32.90M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 89.40K | +0.1% | $25.69M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 77.06K | +1809.9% | $22.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 21.61K | -28.6% | $6.21M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 18 | Fisher Asset Management ✦ | 18.59K | 0.0% | $5.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 8.80K | +477.1% | $2.53M | 0.0% | ▲ Add | 5 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 844 pemegang, 41.22M saham, $23.10B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 2.00K lbr · $1.08M
Officer, Director · 633 lbr · $340,039
Officer, Director · 40 lbr · $21,043
Officer, Director · 1.93K lbr · $1.04M
Officer, Director · 240 lbr · $128,312
Officer, Director · 1.13K lbr · $606,326
Officer, Director · 400 lbr · $217,262
Officer, Director · 480 lbr · $261,830
Officer, Director · 400 lbr · $214,356
Officer, Director · 40 lbr · $21,840
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi